Establishment and Bioinformatics Evaluation of the Ethanol Combined with Palmitic Acid-Induced Mouse Hepatocyte AFLD Model (the Hu-Qiu Model)

Fengjun Qiu,Rui Zeng,Du Li,Tingjie Ye,Wei Xu,Xiaoling Wang,Xiaofeng Yan,Hua Li,Xudong Hu
DOI: https://doi.org/10.1016/j.heliyon.2023.e19359
IF: 3.776
2023-01-01
Heliyon
Abstract:Chronic alcoholic liver disease has brought great harm to human health. Alcoholic fatty liver disease is the first stage in the progression of all chronic alcoholic liver diseases. At present, there is no cell model that fully matches the etiology (high-fat diet + alcohol) of human alcoholic fatty liver disease. We used 100 mM ethanol +6.25 μM PA to establish the ethanol combined with PA-induced mouse hepatocyte AFLD model (EP-AFLD hepatocyte model) and performed the RNA-seq transcriptome sequencing. Through bioinformatics analysis and comparison, we discovered that the EP-AFLD hepatocyte model was more suitable for studying the pathological mechanism of AFLD than the mouse AFLD hepatocyte model induced by ethanol alone. And through bioinformatics analysis, we further discovered that 77 genes from the differential expression gene set of EP-AFLD hepatocyte model were engaged in the pathological process of mouse AFLD and 40 genes were involved in the pathogenesis of both mouse AFLD and human AFLD. In this study, a novel mouse hepatocyte AFLD model was successfully established by combining ethanol and PA, which can be used to study the molecular mechanism of the pathogenesis of AFLD in mice or humans. This study will provide a brand-new in vitro experimental platform for the in-depth study of AFLD pathogenesis and the screening of AFLD therapeutic drugs.
What problem does this paper attempt to address?